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CD86 (B70/B7-2) has recently been identified as an 
alternative CD28/CTLA-4 ligand on activated B cells. 
CD86 has also been demonstrated as possibly serving 
as a primary costimulatory molecule in the initial 
immune response. Since the human Langerhans cell 
is one of the most potent antigen-presenting cells, we 
examined whether CD86 expression and function are 
found on organ-cultured skin, freshly isolated Lan-
gerhans cells, and cultured Langerhans cells in nor-
m al human epidermis. Immunohistochemical study 
in situ revealed that CD86 was expressed on dendritic 
cells with CD1a antigen in organ-cultured but not 
fresh skin. 
Fluorescence-activated cell sorter analysis revealed 
that no staining for either CD80 or CD86 was ob-
served in freshly isolated Langerhans cells but that 
both CD80 and CD86 were expressed on cultured 
Langerhans cells. The actual expression of CDB6 on 
cultured Langerhans cells was further confirmed by 
the detection of 70-kDa glycoprotein on Western 
T ce Ll s recognize antigen presented in the context of majo r hi stocompatibili ty co m plex. Maj o r hi stocom-patibility compl ex antigens alone, however. are in-su fl-icient to activated T cells fu lly. Additiona l co-stimulatory molecu les are "cq uired to p ro mote 
o ptimal T cell activatio n [1-9] and to preven t induction of allergy 
[5J. T he most well known CD28 lig and is CD80 (B7/BB1) [10J , 
w hich is expressed on activated B celJ s, T cell s, macrophages, and 
dendriti c cell s [11-17] . An alte rnative second ligand for CD28 and 
CTLA-4 h as been cloned and designated B70 [1] o r B7- 2 [3] . 
Recent studi es have demonstrated t hat B70, o r B7- 2, is ide n tica l 
to CD86 differentiation antigen [18,1 9]. T he ligatio n of the T cell 
CD28 by CD80 or CD86 on antigen-presentin g cells results in 
cytokine production, T cell prolife ration , and the generatio n of 
cytotoxic T lymphocytes [20 - 22] . CD86 is constitutively present 
on resting monocytes and pe riph eral dendritic cells [1 J, whe reas 
CD80 is not fou nd o n monocytes until afte r stimu lation [23J. Like 
CD80, CD86 express io n is upregulated on B cells fo llowing 
stimu lation with anti-la, an t-Ig, ;ll1ti-CD40, tipopo lysaccharide, and 
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blot analysis . Analysis of polymerase chain reaction 
demonstrated that both CD80 and CD86 were specif-
ically amplified from purified cultured and freshly 
isolated Langerhans cells but not from Langerhans 
cell-depleted epidermal cells, indicating that both 
CD80 and CD86 genes were expressed by Langerhans 
cells. The functional importance of CD86 011 Lan-
gerhans cells was confirnled by the allogeneic CD4 T 
cell proliferative responses with enriched Langerhans 
cells. A monoclonal antibody against CDB6 caused 
81% inhibition in contrast with 29% inhibition pro-
duced by anti-CDBO monoclonal antibody. This in-
hibitory effect was enhanced to 85.3% inhibition 
when a combination of anti-CD86 and anti-CDBO was 
administered. These results indicate that CD86 is 
predominantly expressed on the surface of cultured 
Langerhans cells and may transduce a primordial 
costinlulatory signal in the interaction of Langer hans 
cells and T cells. Key words: CD861T cell a.ctivatiotl. 
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inte rleukin-4 [1, 2,6-9,24,25J and on m o nocytes fo llowin g stimu-
lation with inte rferon-y [l ,23] . CD86 o n B cen s h as been re ported 
to be induced with m ore rapid kinetics, however, and to be 
expressed as a high er level con tinuo usly after stimulation compared 
w ith CD SO [6,26J. 
Lan gel'hans cell s are dendriti c, m arrow-de rived myelo id cells 
located in epidermis. T he Lan gerh ans cells constitute one of t he 
most potent antigen-presenting cells ;11 ,, ;rro and ;11 11 ; (10 and are 
responsible for the ability of normal epidermal cell s to indu ce 
all ogeneic T ce Ll proli feration (27] . Alth ough CD80 has recently 
been reported to be e)..'pressed on the keratinocytes and e piderm al 
dendritic cells ill t issue section [2S], and CTLA- 4 ligand to be 
expressed on cultured Langerhans cells and to costimulate alloge-
neic T cell r esponses [11] , it remain s unclear w h ether human 
Langerhan s cells in various states express b oth CD80 and CD86 . III 
the present study , we examined the expression and function of 
CD86 compared with CD80 in b oth fi:eshly isolated and cultured 
Langerhans cells. 
MATER.IALS AND MET HODS 
Preparation of Enriched or Purified La l1gerhal1s Cells Epidermal 
ce ll s were obtained fiom normal skin removed during plastic surgery. The 
procedure (or iso lating basal epidermal cells from epidermis was previously 
described 129]. Briefl y, after several washes in " complete mediul11" (RPM! 
1640 cOlltaining 10% heat-inactivated feta l bovine serum , 2 111M L-
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glutamine, 50 ILg/ m l gentacine, 100 U/ml penicillin), epidermal cell s were 
resuspended at a density of 5 X 10" /ml in complete medium and seeded in 
150-crn 2 tiss ue cu lture flasks. After a l-h incubation at 37°C, nonadherent 
ce ll s wcre collected by vigorous pipetting. After onc washing in nonsupple-
mented RPMI 1640, the nonadherent cell population was pelleted and 
resuspended in ice-co ld. hypoosmolar phosphate-buffered saline (PBS) 
using simultaneous light-speed vortexing. T his procedure was terminated 
by adding an excess of washing medium when the viab ili ty of the cc ll 
suspcnsio n had droppcd to a Icvel of 1 0-20%. Mter two was hes . 10 ml of 
the epidermal ccll suspensio n (5 X 10"/ml) was layered o n top of 20 ml of 
Ficoll-Hypaquc solution (density = 1.007: Lymphoprep; Nygard & Co .. 
Oslo, Norway) and centrifuged at 1200 rpm for 15 min at room tempera-
ture. T hereafter, cell s were collected fi·om the inte rf;lce, rinsed twice in 
complete medium, and then cultured for 12 or 24 h, counted and tested for 
viability , and subjected to anti-CDI a immuno labeling (see below). Enrich-
m ent of Langerhans cell s was nsuall y 17-53%. 
The separation of CD la + Langerhans ce lls for the preparation of 
Langerhans cell-depleted epidennal cell s or for the purification of Langcr-
hans ce ll s was achieved according to the manufacturcr's protocol. Briefly, 
1-2 X 107 ep idermal cells werc incubated in 5 ml complete medium 
containing 0.5 ILg/ml anti-CDI a monoclonal antibody (MoAb) (OKT 6; 
Orth Diagnosti c Systcm Inc, Nj). Epidermal cell s were incubated for 30 min 
o n icc, washed, and resuspended in 5 ml pBS/:t 'X, fe tal bovine serum. This 
cell suspension was incubated with 50 ILl goat anti-mousc IgG covalentl y 
bound to magnetic polystyrene beads (Dynabeads M-4S0; Dynal A.S., O slo, 
Norway) for 1 h at 4°C. Cells attaching to the beads were pelleted by 
app lication of a magne tic fie ld; adherent ce lls (COl a + cell s > 95%) and 
nonadhercnt cell s (C D I.a + cells < 0.05%) were collected , washed, and 
processed for protein or RN A extraction. 
Skin Organ Culture Normal human split-thickness skin obtained from 
plasti c surgery was used in thi s experiment. The skin was sli ced to a I-mm 
thickness and cut into approximate ly 3 X 3-mm pieces. These were placed 
dermis- side down on paraffin-liJ11med lens paper grafts and floated on the 
top ofK-Gil culture medium (Kutrabou, Osaka, japan). The skin specimens 
were subsequently recovered aftcr 12 and 24 h, and processed for immu-
nohistochemical stud y. 
IJ:1l1Tlunohistochcln ical Study The inl1nuno histochcrnical staining pro -
cedure employed in this study was tile biotin-streptavidin amplified method 
using the Histofine immunosra ining system (Nichirei, Tokyo. japan). Five 
micrometer cryos tat sec tions of split-tluckness skins were prepared and 
fixed in acetone for 3 mill at room temperature. The sectio ns werc washed 
with PBS and preblocked in 10% rabbit se rum and 1 % human All serum for 
30 min at room temperature, thcn incubated in tI,C primary MoAb 
overnight at 4°C. Sectio ns were then consecutivel y incubated with bioti-
nylated-goat anti-mo usc immunoglobin for 15 min and w ith peroxidase-
conjugated streptavidin for 5 min . Sections were washed three times with 
PBS between incuba tions. The final incubation was ill 0.025% diaminoben-
zidinc and 0.01 % H 20 z buffered with 0.1 M Tris-HC I, pH 7.2, for 3 min . 
The scc tions were coun terstaincd li ghtl y with hematoxy lin. 
ImnlunoBuorescence Analysis of Cell Suspension Epidermal ccll 
suspensions enri ched fo r La ngerhans cell s as desclibed above were cul tured 
for 12 to 48 h in complete medium in 24-well plates (Corning, # 25820·1) at 
37°C under 5% CO 2 ai r. After the epidenll al cell s were rinsed in ice-cold 
PBS containi ng 0.1% sodiulll <Izide (NaN, ) with 1% feta l bovine serUlll , 
the)' were tI,en incubated for 30 min with 2.5 ILg/ml of the fluoresce in 
isothiocyanate-Iabeled anti-CDl a (OKT6 ; Ortho Diagnostic Systems Inc .. 
Raritan. Nj) or the appropriate fluo rescein isothiocyanate-Iabcled IgG 1 
control. After a short exposure to normal mo use serum. ce lls were 
incubated with either phycoerythrin-labeled anti-CD80 (L307; IgGl, 5 
ILg/rn l) or phycoerythrin-labeled CD86 (IT2.1 ; IgGl, 5 ILg/ ml) MoAbs 
11 ,30J o r ti,e appropriate isotype contro l (phycoerythrin-mouse IgG I ' 5 
ILg/ ml; BD. San J ose, C A). IT2.1 MoAb was generated by fu sing 1'301 
myeloma cell s w ith splenocytes from BALB/c mice immunizing with jY 
B-LC L [1]. 
Flow cytometry was performed by using a Leitz Vario OrtilOmat 2 
fluorescent microscope o r FACS (fluorescence-activated cell sorter) Ana-
lyze r (130), using 10,000 cells/sample. Dead cell s were gated out with 
ethidium bromide. 
Primary Allogeneic Mixed Epidc.rmal Cell-Lymphocyte Reaction 
Periphera l blood mononuclear cell s were prepared by Ficoll Paque (Phar-
macia. Uppsa la. Sweden) gradient fractio n of b lood drawn from normal 
donors w ithin 20 h . T cells were purified from the peripheral blood 
m ononuclear cel ls as fo llows. Periphera l blood mononuclear cell s (107 
cells/ml) were incuba ted with 5 ILg/ ml each of anti-C D8 MoAb (OKT8; 
Ortho Diagnostic). anti-CDl1 b MoAb (Pham ingen ., San Diego, CA). 
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anti-CD19 MoAb (Phamingen), anti-HLA-DR MoAb, and anti-CDl 6 
MoAb (Phamingen, San Diego, CA) for 30 min at 20°C, washed, and 
resuspended at 2 X 107 cells/ml. Anti-mo use IgG-coated paramagnetic 
beads (Becton Dickinson Labware. Bedford, MA) were added to ti,e ceil 
suspension , which was incubated for 30 min and placed in a magneti c field. 
Non-magnetic cell s were pre incubated with fresh beads in a second tube. 
Non- magnetic ce lls fro m this step werc > 99% C D4 +T cells based on 
two-color immunofluorescence tests witll directl y labeled Mo Ab to CD3, 
CD4, and CD8. Stimulator cells consisted of cu ltured LlIlgerhans cells or 
Langerhans cell-depleted epiderma l cell s. Enriched cul tured Langcrhans 
ce ll s were prepared by ti,e previo usly described method [29]. 
One to 102 X 10' Langerhans cells/ well were seeded as stimulator cells. 
R esponders and stimulators were co- cultured in 96- well round bottoon 
wells at 37°C in 200 ILl of complete medium. For blocking experiment, " 
fina l concentration of 0.1 to 10 ILg/ml MoAbs (IT-2.2. L307, or F[ab'], 
TN228) was added at ti,e initiation of the assay. Anti-CD28 hybridOl\la cell 
line TN228 was generated by immunizing DALB/c mice with human CD28 
transfected murine fibroblast L cells and fusing immune sphenoc)'tcs with 
1'301 myeloma ce ll s. C ultures were pu lsed overnight w itll 0.2 /lCi 
[,H)TdR., and incorporated radioactiv ity was assessed by liquid scintillation 
counting [27]. 
Immunoblotting of Epidermal Cells Purified Langerhans cells (98% 
CDla +) and Langerhans cell-depleted epidermal ce ll s «0.05% C Dla+ 
cells) purificd by the paramagnetic bead technique were washed with PBS 
and homogenized in extraction buffer (50 mM Tris-HC I, pH 7.4, 2% 
sodium dodecyl sul fate, 10 mM N-e th}'1 malaimide. 10 mM ethylenedia-
mine tetraacti c acid , 1 mM phenylmethylsulfonyl fluoride . and 1°/., f3 
mercaptoethanol [31 j) , and the extract was subjected to sodiu lll dodecyl 
sul fate polyacrylamide gel electropho resis nsi ng a 10% gel. The electropho-
resed materials were transferred to C lear B lot m cmbrane-P (Atto Co., 
Tokyo,japan) at a constant vo ltage . The membranes produced were treated 
with 0.05% Tween 20/pBS at room temperature overnight to relllove 
sodium dodecyl sul fate and then with 10% bovine serum albumin to cover 
the untreated sites on the l11c nlbranc. After \va shing, the I11Cnlbrallcs were 
incubated with 10 ILg/ ml anti-CD8o (IT-2.1) or isotype controllgGl at 4°C 
overnight. After washin g, the membranes were further incubated with 
:t :100 peroxidase-conjugated Fab of anti-mo use IgG antibody at rOOIll 
tcmperature for 2 h and then developed with 0.1 % diaminobellzidinc 
tetrahydrochloride (0.1 M Tris-H C I buffer. pH 7.2) and 0.02% H2 0 z· 
Analysis of Epidermal Cell mRNA Tota l cellular I~A was isolated 
from 1.2 X 106 pUlified cultured Langerhans ce ll s (94% CDl a + cell s) that 
had been incubated at 37°C in complete medium for 24 h, ·1.2 X 10· 
purified fre shl y iso lated Langerhans cells and Langerhans ceil-depicted 
epidermal ce ll s. Using l~A zo l (Cinna/ Biotech Lab. Houston, TX), 100 
ng of tota l l~ A was then reverse transcribed in the presence of RA V 2 
reverse transcriptase (BRL, Bethesda. MD). For cDNA synthesis, 4 ng/ ml 
o f tota l cel lular RNA solu tion was heated at 65°C for 5 min alld cooled 
rapidly. After adding 1 ILl of lO X polymerase chain reaction (PCR) butfer 
(500 mM KCI, 100 mM Tris-HcI Buffer, pH 8.4. 15 mM M t;Clz, 0.01 % 
gelatin) 1 m l of25 mM Cl' NTp (Takara, j apan) , 1 ILl of 1 OX hexanucleotide 
mixtnre (Boehringer Mannheim, Mannheim. Germ any), 1 ILl of 100 111M 
dith iothreito l (Boeringer Ma llllheim) , 20 U of libonuclease inhibitor 
(Takara, Kyoto , Japan) , and 3 U of RNA-2 reverse transcriptase, the 
mixtme was incubated at 42°C for 60 min, he;lted at 94°C for 5 min . and 
qllick-chiJlcd 011 ice. Po lymerase chain reaction was perfo rmed to amplify 
the cD NA of CD80 and CD86 [1,32]. Eqnal amounts of cDNA were used 
in each PCR. The PC R reaction mixture contained 10 ILl of cDNA , 5 ILl of 
lO X PCR. buffer . 8 ILl of1.25 mM Cl' NTP, 207 ILl of DE PC-water. 5 ILl of 
20 I'M 5' alld 3' primers and 1.5 U of Tag polymerase (Perkin Elm er Cetus, 
Norfork, CT). To ampli fy the cDNA ofCD80 and C D 86, the amplifica tion 
was conducted at 94°C for 1 nun , 60°C for 2 min, and 72°C for 3 min for 
40 cycles for CDSO and for 30 cycles for CD86. To amplify eDNA of 
fj -actin , the amplifi cation was conducted for 25 cycles at 94 °C for 30 scc. at 
55°C for 30 sec, and at 72°C for 60 sec . 
The forward alld reverse human CD80 DNA primers were 5' primer, 
CATCCAAGTGTCCATACCTC (nt 32- 51) alld 3' primer, CTCTCAT-
TCCTCCTTCTCTC (nt 817- 836) (1). T he forward and reverse human 
CD86 DNA primers were 5' primer. TCTTTGTGATGGCCTTCCTG (nt 
20 - 39) and 3' primer, CTTCCCTCTCCATTGTGTTG (nt 834 - 853) [1] : 
and the fj-actin DNA primers were 5 ' primer. CCTTCCTGGGCATG-
GAGTCCTG , and 3' primer , GGAGCAATGATCTTGATCTTC (202 bp) 
[32]. The specific primers were synthesized by the phosphoramide method 
using a DNA synthesizer (model 392 pCR-MATA; Applied Biosystellls. 
Inc., Foste r C ity. CA) and purified o n Sephadex G50 column (Phalllacia 
LIrn Biotechnology, Gaithersburg, MD) and by high-performance liqnid 
chromatography. T he sequences of p';mers arc spec ific as comfi rlll cd . pCR 
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Figure 1. Iml11ul1ocytochenlical stmnmg of C086 on cultured 
human Langerhans cells. C ryostatic sections of o rgan-cultured skin at 
37°C for 24 h (A) w ere subjected to MoAb anti-CD8G. and cryostatic 
sections of the fresh skin (B) were subjected to MoAb anti-CDS6. Sta ining 
is observed o n ep idc nnal dendriti c cell s (-). and also o n de rmal dendritic 
cell s (t). Senle bflrs, 50 ,..111. 
products \·vere detected by elec tropho resis 0 11 1.7IX> agarosc gel conta inin g 
ethidilll11 bromide. 
RESULTS 
Cultured Langerhans Cells Express Both COSO and COS6 
T he fo cus of our attention was o n whether freshly isolated o r 
c ultured Langerhans cells express CD86 as well as CDSO . To 
determin e if these La ngerhan s cells express CD86. w e investigated 
the CD86 expression on cryosections fr0111 fi'esh or cul tured human 
skin by immunohistochemistry using the <Inti-CD86 MoAb (IT2.1). 
When attempts to stain the cryosections of freshly prep:n'ed human 
skin by anti-CD86 MoAb were conducted . no sta ining was de-
tected (Fig 1B). In addition. in th ese human skin cryosections . 
when skins were cultured fOl' both 12 and 24 h, staining was fo und 
to be present on dendritic ce.ll s not o nly in a suprabasal localiza tion 
in the epid ermis but al so in the uppe r dermis by using anti -CD86 
(Fig 1A). 
To ascertain w hethe r the CD86-positive epidermal dendritic 
cel1s were indeed Langerhans cel ls, we performed a double-labeling 
experiment lll1d Aow cytollletric analysis on 24-h cultured enriched 
Langerhan s cell s usin g anti-COSO Mo Ab or anti-CD86 and anti-
COla reagen ts. Both anti-COSO and anti-C086 MoAbs reacted 
with CD1a+ cells cul tured for 24 h . After culturin g for 24 h. 46'X, 
ofCDla + cell s and 59% of CD I a ' cell s were expressed CD80 and 
CD86, respectivel y (Fig 2E,F) though neither C080 nor CD86 
was detected 011 freshly isolated CO la + cells (Fig 2B,C). 
B iochemica l characterization of the anti -CD86 MoAb reactive 
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structure by it11l11ulloblot ana lysis on Iysates from pl1l;fied cultured 
Langerhans cells revea led a structure of an apparent mass of70 kDa 
(Fig 3, lall e 2), w hich is consistent with the CD86 molecule. T he 
fact that Iysates frOI11 Langerhans cel1-depleted epidermal cells 
failed to rea ct with anti-C086 antibodies (Fig 3 , lall e 1) stro ngly 
indicates that C086 expressio n is restricted to Langerhans cells in 
the epidermal componen t. 
Expression of COSO and C086 mRNA by Cultured and 
NOllcultured Epidermal Cells C080 and CD86 mRNA ex-
pression in cultured and no ncul tured Langerhans cells W'IS studied 
by reverse t ranscriptas,,-~coupl ed PCR. Both CD80 and CD86 
mRNA were detected in purified fi'eshly isolated Langerhans ceUs 
as well as in a C080 and CD86 ex pJ'essed in purified cultured 
Langerhans cell s (Fig 4, lalles 2-4), though neither C080 nor 
C086 mR . .NA was detected in Langerhalls cells dep leted e pidermal 
cell s (Fig 4, lalle 1). CD80 DNA was successfull y amplified frOI11 
human C080-transfected murine P8l5 mastocytoma cell line 
term ed DT 30 (Fig 4, lall e 6) and CDS6 was also amplifi ed from 
C086 transfected IllUl'iJl e P81S cell lill e termed IT 14 (Fig 4, lall e 
5). 
Anti-COSO mAb and anti-COS6 mAb Efficiendy Inhibits 
Primary Allogeneic Mixed Epidermal Cell-Lyn~phocyte 
Reaction It was of interest to learn w hether CD80 or CD86 
might affect the Langerhan cell-mediated allostimulation ofT cells 
and to compare the possible roles of CD80 and CD86 in this 
response. R esponder CD4+ T cells were prepared by immunomag-
netic negative selection and were > 99% pUJ'e (see Mnrerials alld 
Jvle/lwds) . Em-icll ed cultured Langerhans ce l1 s were used as stimu-
lator cell s (17~53% CD1 ' cells) and radioactive thymidine uptake 
was used to assess T-cell proliferation after va ryin g periods of time_ 
T he data in Fig 5 demonstrate that alloproliferation WaS inhibited 
by anti-C086 MoAb and that treatment with anti-CD80 MoAb 
plus anti-C086 MoAb could generate additive efFects. These 
antibody-caused inhibitory effects were concentration dependent. 
with a half-111,,""1l11al effect appearing at 2 JLg/ ml a.nd a m aximal 
effect ;u-ising at 5 JLg/ml (Fig SA ). 
As shown in Fig 5B, at high numbers of em-iched Langerhans 
cells (105). anti-CD80 MoAb caused 52% inhibition of T -cell 
prolife ration and an ti-COS6 MoAb produced 78% inhibition; both 
antibodies together prod uced 89°1., inhibition. At low numbers of 
epidermal cells (10 ' ), o n the othe r hand, anti-CD80 MoAb ca used 
65'1<, iJthibition, anti-C086 MoAb 84%, and both together pro-
duced 93% inhibitio n . Anti-C028 MoAb produced 61 % inhibition 
of T -ce l1 proliferation (Fig 5). 
The representative of nine experiments is shown in Fig 6 . 
Anti-CD86 MoAb and anti-CD80 MoAb respectively e ffe cted 81% 
(50-92%) and 29% (13-44'X,) inhibitio n of T - cell proliferation. 
Both MoAbs togetber gave rise to 85.3% (64-95%) inhibition _ 
Our next concern was whetheJ' anti-CD28 MoAb (CD28.2) or 
the F(ab')2 fi'agment of anti-CD28 (TN228,IgGl) would also 
suppress a Langerhans cell-mediated alloreaction (Figs 5, 6) . 
Depending on the Langerhans ce lJ concentration, anti-CD28 
MoAb (28.2) caused 60% (50 - 70%) T -ce ll prolifenltion. and 
F(ab' )z fragment of anti-C028 (TN228, IgG l) i.nhibited L'lI1ger-
han s cell-mediated alloreactio n completely (93% inhibition) . This 
inhibitory efFect was concentration dependent, with a half-maximal 
efFect at 1 JLg/ml and a max;mal efFect at 5 JLg/ml (Fig SA). 
D ISCUSSION 
Co-stimulatory sig nals playa crucial role in the activity of antigen-
presenting cells, influencing the outcome of peptide/major l'li sto-
compatibili ty complex molecule recognition by T ceUs 15.33]. 
Abrogation of these accessory signals b y chemi cal fixation or 
ultra violet radiatio n may lead to clonal anergy rathe r th<l11 clo nal 
expansion of ul1pt;med or some activated T cells. T he co-stimula-
tory pathway tha t has received the Illost attention to date is that 
mediated via the interaction of CD28 on T cel ls with o ne of the 
ligands, CD80 or C086, on amigen-presentin g cells [26J. 
R ecentl y, Ca ux et al reported that the Langerhans cell line 
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d e rived fi'om hum an cord blood CD34 ' progeni to r cell s can 
express CDS6 in addit ion to CDSO 11 S], w hic h pl ays a primordial 
rol e during La n gerh ans cell-induced a llo reaction , th o u g h it remains 
unknown wheth er or n ot hum an Lan gerhans cell s express CDS6. 
T h e presen t study was th e refore designed to d etermin e th e expres-
sio n of CDSO ;m d CDS6, an accessory m o lecu le o n fres hl y iso lated 
o r culture d La n gerhan s cells and th e ir cont1; butio n during Lan-
gerhans cell-induced T - cell a ll o reactive pro li fe ration. CDSO was 
ex pressed o n 46'1., of th e CO l ' La n gerhan s cells afte r 24-h 
c u lturin g in agreemen t with the d ata 6:om Symington and G iro lo -
m o ni [11 ,34], w h ereas C DS6 was expressed on 59% of C Dt " 
Lan gerhan s cells b y Auoresce l1 ce-ac tivated cell sorte r an alys is (Fig 
2) . N e ith e r COSO nor CDS6 was d etected o n fi'eshly iso la ted 
.Langerh ans cells. T h ese data agreed with Symington ' s data in 
w h ich th e CTLA4-lg ligand was detected o n cu ltured Langerh an s 
c e ll s b u t not on th ose tha t w e re fres hly iso lated [11] . CDS6 was 
-
-
-
-
21 -
2 3 4 
F ig ure 3 . Itn1nunoblot analysis of CD86 on hlllnan Langerhans 
cells. Puri fied 24-h cultured Langerhans ce ll s (98'X, CO I a" ) and Langer-
hans cell-clt;p leted ep iderl1l al cell s were prepared by l1l eans of immuno-
magnetic separation . Ce ll lysates from puritied cultured Langerhans cell s 
(/alles 2 and 4) and Langerhans ce ll-depicted ep idermal ce ll s (l alles / and 3) 
were separated by 10";', sodium dodecyl sulr.,te-po lyac rylamidc gel electro-
phoresis. electroblotted on nitrocel lulose, and incubated with either the 
anti-COH6 MoAb lT2. 1 (lall es / and 2) or the isotype contro l (lnll es 3 and 4). 
0 0 
128 182 2")) 0 oJ , ~ \ ')2 2"-" 0 !=JJ 1',0 192 2"< 
COla COla COla 
d e tected on the COla " d e ndritic ceIJ s n o t only in th e e pidermis but 
also in the d ermis (Fig 1A). Furthe rmo re, n e ith e r MoAb against 
CDSO nor CDS6 was d etected o n fresh o r c ultured keratin ocytes 
(Figs lA,B; 2). B io ch em ica l c haracterizatio n of th e anti -CD86 
MoAb reactive struc ture by immunoblot ana lys is on Iysates 6'0\\1 
purifi e d c ultured Lan gerhans cells reveale d a structure having an 
apparent molec u lar mass of 70 kDa. T h e lysates from Lan gerhans 
cell- deple ted e p iderma l cell s fa il e d to react w ith anti-CDS6 M oAb. 
Anti-CDS6 M oAb also reacte d w ith a small band of 35- to 
40- kDa p rotein. Azuma re ported 40-kDa polypeptides were re-
v eal ed after deglycosylation ofCDS6 molecu les 11) . I t may be likely 
th at th ese 35- to 40-kDa polyp eptides m ay con stitute th e peptide 
w hi c h was produced by unexpected d eglycosy lation o r proteolysis 
ofCDS6. 
Exp . Exp . 2 
2 3 4 5 6 7 
~-ACTIN 202 bp 
CD 80 804 bp 
CD 86 833 bp 
Figure 4. Both CD80 and CD86 I11RNA arc present in Langerhans 
cells but not in Langerhans cell-depleted epidermal cells. Analysis 
of reverse transcriptase PCR- amplified transc ri pts of /3-acti n , C 0 80, and 
C D86 from enriched human Langerhans cells; both freshly isolated L m-
ge rhans cell s (lall e 2) and those cultured for 24 h (lall es 3 and 4), froJ\! 
Langerhans cell-depleted epiderma l cells (la",' I) . from C D80-transfected 
mastocytoma cell line (P815) (Fig 4 , /all e 6) and C086- transfected P815 
(Fig 4 , /alle 5). Lalle 7. nega tive con tro l (RNA witho ut reverse rral\-
scrip tase). Puri fIed Langerhans ce ll s and La ngerhal1s cell- depleted epider-
mal cell s were prepared by immul1omagl1ctic separation. Ethidium bromide 
sta ini ng of the electrophore ti c ge ls. 
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Figure 5. Enriched cultured Langerhans cell-
induced alloreaction is blocked by anti-CD2S, 
allti-CDS6 MoAb, and anti-CDSO MoAb. Langcr-
hans ce lls were enriched to 46')'0 (17-53% C IJ'l a+ cell s) 
by osmotic shock technique [29]. cultured for 24 h. and 
used as stimulator ce lls for T-cell proliferation. C04 i 
T cells (1 X 105 ) were seeded in the prescncc of '1-1 02 
X '10" of enriched cultured Langerhal1S cells in 96-we ll 
round-bottomed cul ture plates. MoAbs aga inst COS6 
(IT2. 2). COSO (U07) . and CD28 (CD2S.2) were 
added at. 0.1, 0.5, or '1.5 p,g/ ml. respectively. Unre-
lated IgG I was used as tJ, e control at the same con-
cemratiol1S. A) The concentration-dependent cllects of 
MoAbs on em-iched Langerhans cell (lO"/wcll)-in-
duced T-cell aJl orcaction. Pro li feration was revealed 
by r' l-rITdR incorporation after (, d of cul ture. B) The 
effects of MoAbs on a concentration-dependent en-
ri ched Langcrhans cell-induced allorcaction . Pro li fer-
ation was demonstrated by r"H]TdR incorporation 
after (, d of cul ture. Resu lts arc represcnrative of five 
cxpcl;mcl1ts. Values arc expressed as mea n cpm fo r 
triplicate. Error Ilnrs. SD. 
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Taken together, our results d emonstrate that cultured but not 
fres h Langerhans cells express both CDSO and CDS6 molecules, 
though in contrast to Langerhans cells, n e ither fresh keratinocytes 
nor those cultured for 24 h express C086. Our da ta a re consistent 
with the ea rlier findin g that COSO is expressed on the surface of 
Langerhan s cell s cultured for 24 h ['1 '1]. In Symington 's pape r, 
however , the C080 on Langerhans cell s was recognized by CTLA-
19. Their data indi cate that CTLA 4 ligands bu t not COSO is 
expressed on Langerhans cells cultured for 24 h [11] . Giromon i c/ al 
a lso demon strated that COSO rea ctivity was already evident on 
c u ltured Langerh ans cell s after 24-h culture and increased during 
the fo ll owing 2 d o f cu lture [34]. 
We con cluded that both C086 and C D80 were strongly ex-
p ressed on Langerhans ce lls during ce ll suspension cu lture. 
In the present study, we investigated the presence of CD80 and 
C D86 ml~A in human epidermal Langerhans ce lls. Using reverse 
transcriptase PC R , we ha ve shown that purified fresh ly isolated 
Langerhans cells contain low levels of COSO mRNA and that. 
fo llowin g culture, Langerhans cells markedly upregulated COSO 
rnRNA, indicating that C080 expressio n is primari ly m o dulated at 
the lnl~A level. T hese data are consistent with the earlie r finding 
that CD80 (B7- 1) e xpression is regulated primarily at the mRNA 
level [34]. We have also shown that both freshly isolated and 
cu ltured Langerhans cells express CD86 ml~A, but it remain s 
unclear whether C086 expression is regulated at the mRNA level 
R egulatory mechanisms of C086 expression are currently under 
investigation . Both CD80 and CD86 I11R..NA were excl usively 
present in the Langerh ans cell fraction, whereas they were not 
detected in Lan gerhans cell-depleted epiderma l cell s (Fig 4), thus 
confirming that Langerhans cells are the only epiderm al cell type 
expressing CD80 and CD86 uncler normal condition. T h ese up-
regulatio ns that occll1' during cul turin g reflec t th e behavior of oth er 
surr;lce molecul es involved in antigen presentation, such as major 
histocompatibility complex mol ecules, LFA-3. and lCAM-L Fur-
ther, there is evidence that. granulocyte-macrophage colon y- stimu-
lating factor and other epidermal cell-derived cytokines arc at least 
in part responsibl e for the phenotype and fu n ctio nal ch anges 
m anifested by Langerhans and dendritic cells during culture . 
Functional studies d emonstrated that C028 triggerin g is a crucial 
event during Langerhans ce ll-mediated T-cell alloreact.ion , a fin d-
ing co nsistent with previous reports lll-13]. The present resu lts 
further demonstrated C086 to b e th e maj or counter-receptor 
involved in C028 triggering, sin ce anti-CDS6 M oA b ca used 81 % 
(50-92%) inhibition, whereas an ti-C 0 80 M oAb pro duced only 
29% (13-44'Vo) inhibition of T-cell prolife ration. Both M o Abs 
together gen era ted 85.3'0, (64-95%) inhibi tion. C D80 does play 
152 YOKO ZEKI liT il L 
Figure 6. Inhibition of enriched Langerhans 
cell-ind u ced T - cell proliferation. Enriched 
Langerhans cell s (17-53'1., CDl a + cell s) were cul-
tured for 12 h. harvested . and uti li zed as stimu lator 
cell s. CD4 " T ce lls ( I X 105) wcre seeded in presence 
of 105 stimulator cells/well in 96-well round-
bottomed tissue- cul ture plates . MoAbs against 
CD28(28.2). F(ab '), I' ragmen t o f anti-CD28 
(TN228, lgG I). CD86. and CD80 were added at 5 
,..g/ rnl. T he pro life ration was revea led by J' H ]TdR. 
in corporation after (, d o f culture . Percentage inh ib i-
tion was calculated using the fo llowin g fo rm ula: 
U ninhibi ted (cpm) -
Inhib ited (cpm)/ Uninhibited (cpm) X '100% 
,Resul ts are representaLive o f nine experiments and arc 
e" pressed as mean percen tage for trip licate cul ture. 
Error /'"rs. SD. *p < lJ.(ll . w hen compared w ith 
percen tage inhi bi tio n by anti - CD86 MoAb; ** p < 
0.0 1. w hen cOll1paTed with percentage in h ibitio n hy 
TN 228 . 
secondary roles such as a com bination of anti-COSO MoAb, and 
:Int i-COS6 MoAb resul ts in more than S5'},u ab rogation of T-cel l 
acti vation . Such a fm ding suggests that other accessory m o lecu les 
(e.g .• a third C02S li ga nd) can re pl ace these known liga nds . 
We then exa min ed whethe r a CD28-specitic MoAb (C02S.2) 
would also suppress enriched cu ltured Langerhans cell-mediated 
all oreaction and found that CD28.2 ca used 60.1% in hi bitio n (50-
70%). This resul t is consisten t w ith that of Caux in w hich 3n ti -
C02S MoA b caused 50-85'lI" inh ibition of Langerhans cell linc-
ind uced alJ oreaction [1S]. T he reason anti-C028 MoAb cann ot 
completely inh.ib it Langerhans cell-induced aJlo reaction mi gh t be 
that an ti-C 028 MoAb m ay poten tially activate T cells. 1n agree-
m en t w ith this hypothesis. TN228 (anti-C028 MoA b F[ab' ]) 
. in hibited the Lange rhan s ce l.l- ind uced alloreaction com plete ly (Fig 
6). 
T he ratio nale fo r the expression of two m o lecules med iating 
ap paren tly simil ar effects on T cell activation rema ins to be 
elu c i d~l ted . However. diffe rences in the kinetics of up regulation 
dUl;ng 13 ce ll activation [25]. as wcll as its restricted expression on 
germ inal cen ter 13 cell s, may se rve to argue the case for specitic 
roles o f CDS6 lIas"s C080 l35]. R.ecen tl y, Larsen et (/ / have 
dem o nstrated that sp lenic de ndritic ce Ll s ex press a h igh leve l of 
both COSO and CD86 afte r the treatment of gra n ulocyte-m acro-
phage colon y-stim ulating fac to r, whe reas interferon-y enh ances 
the expression of C086 bu t not of COSO [36]. Further studies are 
necessary to c1al;fy w hether d ifferentia l regulatory mechani sm s arc 
also operative in COSO and COS6 expression in hu man La ngerhans 
cells. W hether COSO- or COS6/C028-m ed ia ted signals play a 
functio nal role d urin g cu ta neo us imm une responses is p rescn tly 
un known . Altho ugh Sim on e/ (/ / demonstrated that the altern ative 
T-cel l activation via the 137/C02S pathway m ay con tr ibu te to the 
pathogenesis of skin d isease [37 1. further stud ies sho ul d be under-
taken to in vestigate the ro le of CDS6 and C080 o n pathologic 
im m une responses, specifica lly, con tact dermatitis or atopic derm a-
titis. 
T his "'O r!, II '(IS parlinll y sIIJlpo rlcd iJ " n c~mll l (06670855) j i'Ol ll Ihe M illislr), or 
Ed"cnli,," 'lj'jnl'nll . 
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